Sexual dysfunction and treatment approaches
Abstract
Background: Sexual dysfunction is the most common male sexual disorder, and it may have a profound negative impact on a man and his partner’s lives. Male sexual dysfunction includes erectile dysfunction, diminished libido, and abnormal ejaculation. Despite this, there is misconception about the management of sexual dysfunction in the general population where they perceive sildenafil is effective against any type of sexual dysfunction. So that the current review is aimed at describing different types of sexual dysfunction and the available treatment approaches. Methods: The available literatures were reviewed thoroughly and pooled.Results: The high prevalence of sexual problems was confirmed by data derived from the National Health and Social Life Survey. Even in a cohort of younger men ages 18 to 59, 31 percent suffered from sexual dysfunction. Sexual dysfunction is multi-factorial problem. It may be caused by drugs, psychogenic causes, chronic diseases like diabetes and cardiac problems and trauma. By considering these their diagnosis shouldn’t be overlooked by clinicians and the patients should consult their providers about their sexual problem.Conclusion: The optimal treatment for sexual dysfunction should be individualized, based on a patient’s symptoms, expectations, and underlying variant causes.
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence.
Read the paper
Related studies
- Combining in silico and in vitro approaches to identification of potent inhibitor against phospholipase A2 (PLA2)
- In silico and in vitro studies: investigating the chemical composition, DFT, molecular docking, and dynamic simulation of Satureja candidissima (Munby) Briq essential oil as a potential antibacterial agent
- Quercetin combined with ciprofloxacin and gentamicin inhibits biofilm formation and virulence in Staphylococcus aureus
- In silico study of the mechanism of action, pharmacokinetic and toxicological properties of some N-methylanthranilates and their analogs
- Anticonvulsant Effects of Citronellal, Daidzin, and Phytol, Possibly Through GABAA Receptor and Voltage-Gated Sodium Channel Interaction Pathways: In Vivo and In Silico Studies
- 2-Phenylcyclopropylmethylamine (PCPMA) Derivatives as D3R-Selective Ligands for 3D-QSAR, Docking and Molecular Dynamics Simulation Studies
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.